EGFR and breast carcinoma: In PC-3 prostate cancer, metastatic breast cancer MCF-7 cells and lung cancer cell lines, JWH-015 had anti-proliferative action; moreover, it inhibited the activation of EGFR in ERα breast cancer cells [98,115,116].